Similar articles

• [Long-term outcome in patients with gastric MALT lymphoma after H. pylori eradication].

  Tajika M, Nakamura T, Kawai H, Yatabe Y, Nakamura S. Tajika M, et al. Nihon Rinsho. 2005 Nov;63 Suppl 11:516-9. Nihon Rinsho. 2005. PMID: 16363592 Japanese. No abstract available.
• [Present state and future view of the indications for H. pyloni eradication therapy].

  Takahashi S, Tanaka A, Sugano H. Takahashi S, et al. Nihon Rinsho. 2005 Nov;63 Suppl 11:23-6. Nihon Rinsho. 2005. PMID: 16363498 Review. Japanese. No abstract available.
• [Treatment of peptic ulcer and gastritis associated with Helicobacter pylori].

  López-Brea M, Alarcón T. López-Brea M, et al. Enferm Infecc Microbiol Clin. 1995 Aug-Sep;13(7):422-8. Enferm Infecc Microbiol Clin. 1995. PMID: 8519820 Review. Spanish. No abstract available.
• [Indication of H. pylori eradication therapy].

  Miwa H, Sato N. Miwa H, et al. Nihon Rinsho. 2002 Feb;60 Suppl 2:408-13. Nihon Rinsho. 2002. PMID: 11979816 Review. Japanese. No abstract available.
• [Helicobacter pylori and MALT-type gastric lymphoma: is it sufficient to eradicate the infection?].

  Feu Caballé F. Feu Caballé F. Gastroenterol Hepatol. 1998 Jan;21 Suppl 1:40-4. Gastroenterol Hepatol. 1998. PMID: 9549202 Review. Spanish. No abstract available.